AMIX
AMIX
Positions held
Your positionsAMIX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-30 · Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
2026-09-16 · Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
2026-09-01 · Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
2026-08-25 · Top Midday Gainers
2026-08-25 · Autonomix Medical Shares Surge Pre-Bell After $4.9 Million Warrant Inducement Priced at Premium to Market
2026-08-25 · Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
2026-08-12 · Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
2026-08-05 · Top Premarket Decliners
2026-08-04 · Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion
Price (daily)
Full chart · RSI · MACD · patterns